Pipemidic Acid Production Cost Reports

The report provides a detailed analysis essential for establishing a Pipemidic Acid production plant. It encompasses all critical aspects necessary for Pipemidic Acid production, including the cost of Pipemidic Acid production, Pipemidic Acid plant cost, Pipemidic Acid production costs, and the overall Pipemidic Acid production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Pipemidic Acid production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Pipemidic acid is an antibacterial agent compound that is mainly used for treating urinary tract infections and other infections caused by susceptible gram-negative bacteria. It is widely used as an ingredient in certain pharmaceutical formulations where its broad antibacterial action helps control microbial growth in the urinary system. It is also used to control bacterial growth in patients with frequent or persistent UTIs.  It is also used in some gastrointestinal infections when the bacteria involved are sensitive to this medicine.

It helps reduce discomfort caused by burning, urgency, and lower abdominal pain linked to urinary infections in outpatient care. Moreover, pipemidic acid is also utilised in research laboratories to study bacterial DNA-gyrase activity and to evaluate drug–bacteria interactions.

The demand for Pipemidic Acid is mainly driven by its utilisation as a targeted antibacterial agent for managing specific gram-negative infections, which largely contributes to its market growth. Its application as a quinolone-based antibacterial agent used for treating urinary tract infections and other gram-negative bacterial infections further enhances its demand in the medical and pharmaceutical industries. Growth in outpatient care, rising infection cases, and the need for cost-effective oral antibiotics also strengthen its demand in the healthcare and pharmaceutical sectors.

In addition, industrial Pipemidic acid procurement depends on factors such as the cost and steady supply of key raw materials, regulatory standards for antibiotic production, and quality-control guidelines. Improvements in production methods, supplier consistency, and safe handling practices, along with efficient distribution systems, also play an important role in shaping the global procurement processes for Pipemidic acid.

Raw Material for Pipemidic Acid Production

According to the Pipemidic Acid production plant project report, the major raw materials for Pipemidic Acid production include Ethyl 2,4-dichloropyrimidine-5-carboxylate and Ethyl β-ethylaminopropionate.

Production Process of Pipemidic Acid

The extensive Pipemidic Acid production cost report consists of the following industrial production process:

1. Production via Condensation: The production process of pipemidic acid begins with the condensation of ethyl 2,4-dichloropyrimidine-5-carboxylate with ethyl β-ethylaminopropionate, which facilitates both coupling and ring closure to form 2-chloro-5-hydroxy-7,8-dihydro-8-ethylpyridine[2,3-d]pyrimidine-6-carboxylate. Then, this intermediate is subjected to bromination to activate the molecule for the next step, where it is reacted with piperazine, which forms an important structural part of pipemidic acid. The resulting compound is hydrolysed to remove the ester group and convert it into the corresponding acid, followed by neutralisation and purification to obtain pipemidic acid as the final product.

Pipemidic acid is a quinolone-type antibacterial agent that appears as a white to pale yellow crystalline powder and is generally odourless. The molecular formula of the compound is C14H17N5O3, and its molar mass is about 303.32 g/mol. The solid does not have a defined boiling point, as it breaks down when heated, and it melts with decomposition around 253–255 degree Celsius. It shows limited solubility in water but dissolves more readily in dilute acids or alkaline solutions. The solubility of the compound in water is 0.322 mg/mL at 25 degree Celsius. It is handled as a stable solid under normal conditions. The IUPAC name of the compound is 8-ethyl-5-oxo-2-piperazin-1-yl-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid. It is advised to be careful while working with it, as exposure may lead to irritation or other health issues, and routine protective gear is recommended during handling.